Landmark deal: Israeli companies team to market MMJ inhaler

Two Israeli companies have signed an agreement to market an inhaler for medical marijuana, signifying what looks to be the first time a major global pharmaceutical company has agreed to market an MMJ product.

Teva Pharmaceutical Industries Ltd. and Syqe Medical said they inked a distribution and cooperation agreement for Teva to exclusively market Syqe’s inhaler, which has been used for more than a year at an Israeli hospital under a trial program, the Times of Israel reported.

Syqe said the deal is the first of its kind involving a big pharmaceutical company and a medical cannabis

...

Landmark deal: Israeli companies team to market MMJ inhaler is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs